Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-30

FDA Approved: FEBUXOSTAT — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original Abbreviated New Drug Application for febuxostat (generic) by Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

ORIG AP for FEBUXOSTAT (FEBUXOSTAT)